Assessment of the knowledge, preferences and concern regarding the prospective COVID-19 vaccine among adults residing in New Delhi, India – A cross-sectional study

Islam, Farzana; Agarwalla, Rashmi; Panda, Maitreyee; Alvi, Yasir; Singh, Vishal; Debroy, A; Ray, Arindam; Vadnerkar, Amruta; Uttekar, Shraddha

doi:10.4103/jfmpc.jfmpc_2437_20

Cited by 17 publications

(5 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After excluding each study and calculating the overall estimation, the pooled prevalence rate was unchanged (26.5%, 95% CI [22,31]). Danabal et al, 2021− Dara et al, 2021− Godasi et al, 2021− Goruntla et al, 2021− Hossain, Rana, et al, 2021− Islam, Agarwalla, et al, 2021− Islam, Siddique, et al, 2021− Jacob et al, 2021…”

Section: Sensitivity Analysismentioning

confidence: 99%

Prevalence of COVID-19 Vaccine Hesitancy in South Asia: A Systematic Review and Meta-Analysis

Islam¹,

Yunus²,

Akib³

et al. 2023

JPSS

View full text Add to dashboard Cite

Vaccine uptake and coverage in susceptible populations are needed through effective vaccination campaigns to address the COVID-19 pandemic in South Asian countries. We aimed to measure the pooled proportion of COVID-19 vaccine hesitancy in this regard. Research articles published between January 1, 2020, to December 31, 2021, were searched through Medline, PubMed, Cochrane, Google Scholar, and the WHO COVID-19 database. The Joanna Briggs Institute (2014) tool for prevalence studies was used to assess data quality. We performed a meta-regression test and a sensitive analysis among the studies and used the DerSimonian and Laird random-effects model to measure the pooled effect estimates. Subgroup analyses were performed concerning vaccine hesitancy, countries, study population, study level, and the time since the first outbreak of the pandemic. A total of 43 studies out of 598 published articles across the eight countries in South Asia were included. The pooled proportion of COVID-19 vaccine hesitancy was 26.5% (95% CI [22, 31], I2 = 99.59%). Vaccine hesitancy was higher in Afghanistan (37%), Pakistan (33%), and Bangladesh (28.9%); among the general population (29%); at community levels (27.9%); and the duration of time of 1–12 months since the first outbreak in each country (27.5%). Vaccine hesitancy exists in South Asia with different rates among countries, population sub-groups, communities, study- levels, duration of time since the first outbreak, and study population. Therefore, enhancing public awareness of vaccination and vaccine hesitancy is required to prevent future pandemics.

show abstract

Section: Sensitivity Analysismentioning

confidence: 99%

Prevalence of COVID-19 Vaccine Hesitancy in South Asia: A Systematic Review and Meta-Analysis

Islam¹,

Yunus²,

Akib³

et al. 2023

JPSS

View full text Add to dashboard Cite

show abstract

“…A study was conducted among healthcare workers nationwide, which revealed that 84.1% of them accepted the vaccine, as they trusted the initiative by the government of India and the data from previous research [ 26 ]. In another study, studies were conducted on healthcare workers, and more than 50% of healthcare workers in Delhi were acquiescent to the vaccine, and 72% felt that immunisation should first be provided to front-line workers [ 20 ]. Kaur A. et al assessed the acceptance of the COVID-19 vaccine, and some participants (45.5% dental and 48.4% medical) expressed worry about unanticipated vaccination side effects.…”

Section: Discussionmentioning

confidence: 99%

“… Acceptance of the COVID-19 vaccine in India according to residence, as shown in the form of a forest plot [ 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ]. …”

Section: Figurementioning

confidence: 99%

Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis

et al. 2023

View full text Add to dashboard Cite

This systematic review and meta-analysis sought to evaluate the acceptability levels for COVID vaccine(s) in various states in India. Published articles in PubMed/Scopus/Cochrane/DOAJ/the Web of Science that focused on assessing COVID-19 vaccine hesitation/vaccine acceptance using a survey/questionnaire were included. After extensive research, 524 records were found, and after screening on the basis of eligibility criteria, only 23 papers were added to this review. Increased vaccine assumption percentage (>70%) among the population was found in two surveys nationwide (92.8%) and in Delhi (79.5%). For pooled estimates of COVID-19 vaccine acceptance and heterogeneity, twenty-three studies (23) consisting of 39,567 individuals reported for acceptance of COVID 19 vaccine in India.. Out of these, 26,028 individuals accepted the COVID-19 vaccine, giving a pooled estimate of 62.6% (95% CI: 55.6–69.4) with considerable heterogeneity (χ2 = 3397.3, p < 0.0001; I2 = 99.40%). The results of this study give a brief insight into the percentage acceptance and hesitancy among the Indian population regarding COVID-19 vaccine immunisation. Future research and vaccine education initiatives can be steered by the findings of this work as a starting point.

show abstract

“…Regionally, India has reported 63% to 80% acceptance. 17 , 18 In Bangladesh the vaccine acceptance ranged from 61% to 79%. 19 , 20 In both the countries the acceptance has increased over time.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 vaccine acceptance and its drivers among Pakistani population

Rehman

Arif²,

Jawad³

et al. 2023

Pak J Med Sci

View full text Add to dashboard Cite

Background & Objective: COVID-19 vaccine has become available within a record time but mere availability will not control the pandemic. High vaccine acceptance is required. The objective was to determine COVID-19 vaccine acceptance and its associated factors among Pakistani population. Methods: An online survey using google form, was conducted from January 31st to February 9th, 2021 before the start of the mass vaccination in Pakistan. The questionnaire had questions about demographics plus vaccine hesitancy. We received a total of 1156 responses. Data was analyzed using STATA version 14. We employed descriptive statistics and chi square test. Results: A total of 1156 responses were received. 65% were male and 35% female. Only 6% were uneducated. Thirty percent had tested positive for COVID-19 earlier. Forty-six percent of the respondents would take (acceptance) a vaccine if available. Forty-eight percent and 45% were confident in using USA/UK and Chinese vaccine respectively. Gender and marital status was statistically significantly associated with vaccine acceptance. Concerns about the side effects were 55% while for efficacy it was 69%. Twenty-three percent were concerned about the permissibility of the vaccine on religious grounds. Conclusion: Gender and marital status was significantly associated with vaccine acceptance. Forty-six percent respondents were willing to take the vaccine. Among the vaccine hesitant group, respondents were worried about the side effects, safety and religious permissibility of vaccine. Policy makers and all the relevant stakeholders should consider low vaccine acceptance as a major bottleneck and should devise strategies to address this major issue in the fight against COVID-19. doi: https://doi.org/10.12669/pjms.39.2.6051 How to cite this: Rehman K, Arif N, Jawad M, Muhammad A. COVID-19 vaccine acceptance and its drivers among Pakistani population. Pak J Med Sci. 2023;39(2):553-556. doi: https://doi.org/10.12669/pjms.39.2.6051 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

show abstract

Assessment of the knowledge, preferences and concern regarding the prospective COVID-19 vaccine among adults residing in New Delhi, India – A cross-sectional study

Cited by 17 publications

References 17 publications

Prevalence of COVID-19 Vaccine Hesitancy in South Asia: A Systematic Review and Meta-Analysis

Prevalence of COVID-19 Vaccine Hesitancy in South Asia: A Systematic Review and Meta-Analysis

Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis

COVID-19 vaccine acceptance and its drivers among Pakistani population

Contact Info

Product

Resources

About